- Home
- BW vs CLNN Comparison
BW vs CLNN Comparison
Compare BW & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BW
- CLNN
- Stock Information
- Founded
- BW 1867
- CLNN 2012
- Country
- BW United States
- CLNN United States
- Employees
- BW N/A
- CLNN N/A
- Industry
- BW Building Products
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- BW Industrials
- CLNN Health Care
- Exchange
- BW Nasdaq
- CLNN Nasdaq
- Market Cap
- BW 119.1M
- CLNN 120.6M
- IPO Year
- BW N/A
- CLNN N/A
- Fundamental
- Price
- BW $6.73
- CLNN $8.48
- Analyst Decision
- BW Buy
- CLNN Strong Buy
- Analyst Count
- BW 2
- CLNN 6
- Target Price
- BW $5.50
- CLNN $32.67
- AVG Volume (30 Days)
- BW 5.8M
- CLNN 132.8K
- Earning Date
- BW 11-04-2025
- CLNN 11-13-2025
- Dividend Yield
- BW N/A
- CLNN N/A
- EPS Growth
- BW N/A
- CLNN N/A
- EPS
- BW N/A
- CLNN N/A
- Revenue
- BW $721,285,000.00
- CLNN $214,000.00
- Revenue This Year
- BW N/A
- CLNN N/A
- Revenue Next Year
- BW $8.02
- CLNN $1,363.77
- P/E Ratio
- BW N/A
- CLNN N/A
- Revenue Growth
- BW 57.75
- CLNN N/A
- 52 Week Low
- BW $0.22
- CLNN $2.28
- 52 Week High
- BW $7.77
- CLNN $13.50
- Technical
- Relative Strength Index (RSI)
- BW 74.73
- CLNN 47.21
- Support Level
- BW $4.65
- CLNN $8.61
- Resistance Level
- BW $7.77
- CLNN $10.31
- Average True Range (ATR)
- BW 0.65
- CLNN 1.51
- MACD
- BW 0.27
- CLNN -0.33
- Stochastic Oscillator
- BW 76.34
- CLNN 28.22
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.